You just read:

Oncolytic Virus Landscape Report 2017: Takeover of BioVex by Amgen in Late 2011, Worth up to US$ 1 Bln, has Woken up the Field and Became a Game Changer - Research and Markets

News provided by

Research and Markets

Jan 31, 2017, 07:10 ET